Cardiology
Partner With Us
Advertisement
Conexiant chevron_right Cardiology chevron_right ACC 2024 Risks of Topical vs Intravenous Tranexamic Acid in Heart Surgery
Conference News From the Journals

ACC 2024: Risks of Topical vs Intravenous Tranexamic Acid in Heart Surgery

Topical administration of tranexamic acid may be inferior to intravenous administration in patients undergoing heart surgery.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.